|
Optimizerx Corporation (OPRX) |
|
|
|
Optimizerx's Customers Performance
OPRX
|
OPRX's Source of Revenues |
Optimizerx's Corporate Customers have recorded an advance in their cost of revenue by 7.49 % in the 3 quarter 2023 year on year, sequentially costs of revenue grew by 2.12 %. During the corresponding time, Optimizerx Corporation recorded revenue increase by 8.26 % year on year, sequentially revenue grew by 18.19 %. While revenue at the Optimizerx Corporation's corporate clients recorded rose by 9.59 % year on year, sequentially revenue grew by 0.88 %.
• List of OPRX Customers
|
|
Optimizerx's Customers have recorded an advance in their cost of revenue by 7.49 % in the 3 quarter 2023 year on year, sequentially costs of revenue grew by 2.12 %, for the same period Optimizerx Corporation recorded revenue increase by 8.26 % year on year, sequentially revenue grew by 18.19 %.
• List of OPRX Customers
Select the Relationship:
|
|
Select the Category:
|
|
Customers Net Income grew in Q3 by |
Customers Net margin grew to |
|
1.3 % |
Optimizerx's Comment on Sales, Marketing and Customers
We continue to extend our marketing efforts to build both brand and capabilities
awareness in the market. As previously discussed, we continue to actively participate
in industry and partner events such as ExL Pharma and the ACE – Allscripts
Users Conference, as well as having taken a lead sponsor position in the CBInet
eRx and EHR conferences in March of 2017.
We also continue to focus on the expansion of our strategic partnership with
WPP, plc. We plan to continue to increase our marketing efforts with all of
our strategic partners as we continue to promote our platform primarily through:
Industry and Partner Events;
Email Campaigns;
Internet Marketing;
Public Relations Campaigns;
Physician Offices;
Direct to Consumer Marketing;
Trade Media Advertising;
Pharmacy Partners;
Physician Organizations and Associations; and
Strategic Relationships.
|
Optimizerx's Comment on Sales, Marketing and Customers
We continue to extend our marketing efforts to build both brand and capabilities
awareness in the market. As previously discussed, we continue to actively participate
in industry and partner events such as ExL Pharma and the ACE – Allscripts
Users Conference, as well as having taken a lead sponsor position in the CBInet
eRx and EHR conferences in March of 2017.
We also continue to focus on the expansion of our strategic partnership with
WPP, plc. We plan to continue to increase our marketing efforts with all of
our strategic partners as we continue to promote our platform primarily through:
Industry and Partner Events;
Email Campaigns;
Internet Marketing;
Public Relations Campaigns;
Physician Offices;
Direct to Consumer Marketing;
Trade Media Advertising;
Pharmacy Partners;
Physician Organizations and Associations; and
Strategic Relationships.
OPRX's vs. Customers, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
COMPANY NAME |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
Optimizerx Corporation |
211.13 |
62.81 |
-13.75 |
23 |
Cvs Health Corporation |
100,037.72 |
357,776.00 |
8,368.00 |
300,000 |
Rite Aid Corp |
35.86 |
23,475.49 |
-1,635.20 |
50,000 |
SUBTOTAL |
100,073.59 |
381,251.49 |
6,732.80 |
350,000 |
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved. This site uses cookies to make your browsing experince better. By
using this site, you agree to the Terms of Service and Privacy Policy - UPDATED
(Read about our Privacy Policy)
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com